Cramer: We've missed the big move on Sarepta Therapeutics

Jim Cramer provides his opinion on various stocks at lightning speed, including Sarepta Therapeutics.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.